Нарушения ритма и проводимости у больных анкилозирующим спондилитом (болезнью Бехтерева) и псориатическим артритом

А.П. Ребров, И.З. Гайдукова

ФГБОУ ВО Саратовский ГМУ им. В.И.Разумовского Минздрава России, ФГБОУ ВО СЗГМУ им. И. И. Мечникова Минздрава России

Риск появления нарушений проводимости у больных анкилозирующим спондилитом и псориатическим артритом превышает аналогичный риск у здоровых лиц в одногодичной, четырех- и десятилетней перспективе. Риск появления нарушений ритма повышен относительно здоровых лиц и больных анкилозирующим спондилитом у больных псориатическим артритом и ассоциируется с наличием артериальной гипертензии и случаями сердечно-сосудистой смерти.

ключевые слова: нарушения ритма, нарушения проводимости, сердечно¬сосудистый риск, сердечно-сосудистая смертность, анкилозирующий спондилит, болезнь Бехтерева, псориатический артрит.

для цитирования: Ребров А.П., Гайдукова И.З. Нарушения ритма и проводимости у больных анкилозирующим спондилитом (болезнью Бехтерева) и псориатическим артритом. Неотложная кардиология и кардиооваскулярные риски, 2017, Т. 1, №1, С. 117-124.

Rhythm and conduction disturbances in patients with ankylosing spondylitis (bechterev's disease) and psoriatic arthritis

A.P. Rebrov, I.Z. Gaydukova

The risk of conduction disorders in patients with ankylosing spondylitis and psoriatic arthritis exceeds a similar risk of healthy individuals in one-, four- and ten-year perspective. The risk of rhythm disturbances
in patients with psoriatic arthritis is increased compared to healthy controls and patients with ankylosing spondylitis and is associated with the presence of arterial hypertension and cardiovascular mortality.

keywords: rhythm and conduction disturbances, cardiovascular risk, cardiovascular death, ankylosing spondylitis, Bechterev's disease, psoriatic arthritis

for references: Rebrov A.P., Gaydukova I.Z. Rhythm and Conduction Disturbances in Patients with Ankylosing Spondylitis (Bechterev's Disease) and Psoriatic Arthritis. Neotlozhnaya kardiologiya i kardioovaskulyarnye riski [Emergency cardiology and cardiovascular risks], 2017, vol. 1, no. 1, pp. 118-125.

1.Folomeeva O. M., Galushko E. A., Erdes S. F. Rasprostranennost' revmaticheskich zabolevaniy v populyaziyach vzroslogo naseleniya Rossii i SShA [The prevalence of rheumatic diseases in populations of the adult population of Russia and the United States]. Nauch-prakt. revmatologiya, 2008, no. 4, s. 4-13. (in Russian)/
2.Han C., Robinson D. W., Hackett M. V., Paramore L. C., Fraeman K. H., Bala M. V. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. JRheumatol, 2006, vol. 33, no. 11, pp. 2167-2172.
3.Haroon N. N., Paterson J. M., Li P., Inman R. D., Haroon N. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population- based study. Ann intern Med, 2015, vol. 163, no. 6, pp. 409-416.
4.Rebrov A. P., Gaydukova I. Z., Poddubnyy D. A. Kardiovaskulyarnaya patologiya u bol'nych ankiloziruyuschim spondilitom [Cardiovascular disease in patients with ankylosing spondylitis]. Scientific and practical rheumatology, 2012, no. 2, pp. 100-105. (in Russian).
5.Heslinga S. C., Van den Oever I. A., Van Sijl A. M., Peters M. J., Van der Horst-Bruinsma I.E., Smulders Y. M., Nurmohamed M. T. Cardiovascular risk management in patients with active ankylosing spondylitis: a detailed evaluation. BMC Musculoskelet Disord, 2015, vol. 9, no. 16, pp. 80.
6.Ozkan Y. Cardiac Involvement in Ankylosing Spondylitis. J Clin Med Res, 2016, vol. 8, no. 6, pp. 427-430. doi: 10.14740/jocmr2488w.
7.Klingberg E., Svealv B. G., Tang M. S., Bech-Hanssen O., Forsblad-d'Elia H., Bergfeldt L. Aortic Regurgitation Is Common in Ankylosing Spondylitis: Time for Routine Echocardiography Evaluation? Am J Med, 2015, vol. 128, no. 11, pp. 1244-1250.e1. doi: 10.1016/j.amjmed.2015.04.032.
8.Bergfeldt L., Edhag O., Vedin L., Vallin H. Ankylosing spondylitis: an important cause of severe disturbances of the cardiac conduction system. Prevalence among 223 pacemaker- treated men. Ami J Med, 1982, vol. 73, no. 2, pp.187-191.
9.Bergfeldt L. HLA B27-associated rheumatic diseases with severe cardiac bradyarrhythmias. Clinical features and prevalence in 223 men with permanent pacemakers. Am J Med, 1983, vol. 75, no. 2, pp. 210-215.
10.Bergfeldt L., Vallin H., Edhag O. Complete heart block in HLA B27 associated disease. Electrophysiological and clinical characteristics. Br Heart J, 1984, vol. 51, no. 2, pp. 184-188.
11.Van der Linden S., Valkenburg H. A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum, 1984, vol. 27, no. 4, pp. 361-368.
12.Taylor W., Gladman D., Helliwell P., Marchesoni A., Mease P., Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum, 2006, vol. 54, no. 8, pp. 2665-2673.
13.Garrett S., Jenkinson T., Kennedy L. G., Whitelock H., Gaisford P., Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol, 1994, vol. 21, pp. 2286-2291.
14.Lukas C., Landewe R., Sieper J., Dougados M., Davis J., Braun J., van der Linden S., van der Heijde D. Assessment of SpondyloArthritis international Society. Development of an ASAS endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis, 2009, vol. 68, no. 1, pp. 18-24.
15.Wells G., Becker J. C., Teng J., Dougados M., Schiff M., Smolen J., Aletaha D., van Riel P. L. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis, 2009, vol. 68, no. 6, pp. 954-960. doi: 10.1136/ard.2007.084459.
16.Rebrova O. Y. Statisticheskiy anallzmedizinskich dannych. Primeneniepaketaprikladnych programmSTATISTICA [Statistical analysis of medical data. Application of the STATISTICA software package]. Moskva, Mediasfera, 2002, 312 p. (in Russian).
17.Edson-Heredia E., Zhu B., Lefevre C., Wang M., Barrett A., Bushe C. J., Cox A., Wu J. J., Maeda-Chubachi T. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink. J Eur Acad Dermatol Venereol, 2015, vol. 29, no. 5, pp. 955-963.
18.Rebrov A. P., Nikitina N. M., Gaidukova I. Z. Faktory riska razvitiya serdechno-sosudistych zabolevaniy pri psoriaticheskom i revmatoidnom artritach [Risk factors for cardiovascular disease in psoriatic and rheumatoid arthritis]. Ther. Arch, 2011, vol. 83, no. 5, pp. 20-24. (in Russian).
19.Grewal G. S., Leipsic J., Klinkhoff A. V. Abdominal aortitis in HLA-B27+ spondyloarthritis: case report with 5-year follow-up and literature review. Semin Arthritis Rheum, 2014, vol. 44, no. 3, pp. 305-308, doi: 10.1016/j.semarthrit.2014.05.012.
20.Tufan A., Engin Tezcan M., Kaya A., Mercan R., Oner Y., Ozturk M. A. Aortitis in a patient with psoriatic arthritis. Mod Rheumatol, 2012, vol. 22, no. 5, pp. 774-777. doi: 10.1007/ s10165-011-0566-9.
21.Arida A., Protogerou A. D., Konstantonis G., Konsta M., Delicha E. M., Kitas G. D., Sfikakis P. P. Subclinical atherosclerosis is not accelerated in patients with ankylosing spondylitis with low disease activity: new data and metaanalysis of published studies. J Rheumatol, 2015, vol. 42, no. 11, pp. 2098-2105.
22.Gaydukova I. Z., Rebrov A.P, Khondkaryan E. V., Aparkina A. V., Lebedinskaya O. A. Arteri al'naya gipertenziya u bol'nych ankiloziruyuschim spondilitom (bolezn'yu Bechtereva) i psoriaticheskim artritom [Arterial hypertension in patients with ankylosing spondylitis (Bechterew's disease) and psoriatic arthritis]. Arterial hypertension, 2016, vol. 22, no. 5, pp. 495-504. doi: 10.18705 / 1607-419X-2016-22-5-495-504. (in Russian).
23.Gaydukova I. Z., Rebrov A. P. Risk poyavleniya ishemicheskoy bolezni serdza u bol'nych ankiloziruyuschim spondilitom (bolezn'yu Bechtereva) i psoriaticheskim artritom po rezul'tatam desyatiletnego prospektivnogo nablyudeniya (issledovanie PROGRESS) [The risk of coronary heart disease in patients with ankylosing spondylitis (Bechterew's disease) and psoriatic arthritis following a ten-year prospective observation (study PROGRESS)], Klinizist, 2016, vol. 10, no. 3, pp. 26-31. doi: 10.17650/1818-8338-2016- 10-3-26-31. (in Russian).

Полнотекстовая статья

Скачать статью

Формат файла: pdf (244.38 Кб)

→ Главная → 2017 том 1, №1